BIOXCEL THERAPEUTICS INC (BTAI) Top Institutional Shareholders

BIOXCEL THERAPEUTICS INC (BTAI) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $7.35M in BTAI holdings during the latest filing period.

Millennium Management Llc is currently the largest disclosed institutional shareholder of BTAI tracked by InsiderSet, reporting ownership valued at approximately $2.60M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $2.30M, representing an estimated loss of -11.19% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 91% of the total disclosed BTAI value among the investors covered in this analysis. Major shareholders include Millennium Management Llc, Armistice Capital, Llc, Oaktree Capital Management, and several other long-term asset managers with concentrated positions in BIOXCEL THERAPEUTICS INC (BTAI).

This page ranks the largest institutional BTAI shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

38

Total Reported Value

$7.35M

Largest Holder

Millennium Management Llc

Largest Position

$2.60M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

49

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Millennium Management Llc0.00%1,936,760$2,595,258$2,304,744-$290,514-11.19%
Armistice Capital, Llc0.08%1,910,076$2,559,502$2,272,990-$286,512-11.19%
Oaktree Capital ManagementHoward Marks0.01%241,188$323,193$287,014-$36,179-11.19%
Geode Capital Management, Llc0.00%230,168$308,725$273,900-$34,825-11.28%
Vanguard Capital Management Llc0.00%207,339$277,834$246,733-$31,101-11.19%
Jones Financial Companies Lllp0.00%131,789$166,054$156,829-$9,225-5.56%
Man Group Plc0.00%96,473$129,274$114,803-$14,471-11.19%
State Street Corp0.00%92,118$123,438$109,620-$13,818-11.19%
Fmr Llc0.00%90,300$121,002$107,457-$13,545-11.19%
Vanguard Fiduciary Trust Co0.00%84,921$113,794$101,056-$12,738-11.19%
Blackrock, Inc.0.00%84,282$112,938$100,296-$12,642-11.19%
&Partners0.00%80,864$108,358$96,228-$12,130-11.19%
Eversource Wealth Advisors, Llc0.00%1,772$73,857$2,109-$71,748-97.14%
Ubs Group Ag0.00%52,788$70,736$62,818-$7,918-11.19%
Oaktree Fund Advisors, Llc0.10%42,913$57,503$51,066-$6,437-11.19%
Hightower Advisors, Llc0.00%41,000$54,940$48,790-$6,150-11.19%
Northern Trust Corp0.00%36,313$48,659$43,212-$5,447-11.19%
Beacon Pointe Advisors, Llc0.00%18,877$25,296$22,464-$2,832-11.20%
Osaic Holdings, Inc.0.00%16,214$21,726$19,295-$2,431-11.19%
Portfolio Strategies, Inc.0.00%12,178$16,319$14,492-$1,827-11.20%
Diversify Wealth Management, Llc0.00%15,000$15,600$17,850+$2,250+14.42%
Morgan Stanley0.00%10,588$14,188$12,600-$1,588-11.19%
Wells Fargo & Company/Mn0.00%4,319$5,787$5,140-$647-11.19%
Tower Research Capital Llc (Trc)0.00%1,718$2,302$2,044-$258-11.19%
Vanguard Global Advisers, Llc0.00%493$661$587-$74-11.25%
Silver Grove Financial Group, Inc.0.00%334$447$397-$50-11.08%
Washington Trust Advisors, Inc.0.00%160$214$190-$24-11.03%
Annis Gardner Whiting Capital Advisors, Llc0.00%156$210$186-$24-11.60%
Parkside Financial Bank & Trust0.00%112$151$133-$18-11.74%
Bnp Paribas Financial Markets0.00%59$79$70-$9-11.13%
Farther Finance Advisors, Llc0.00%25$31$30-$1-4.03%
Northwestern Mutual Wealth Management Co0.00%21$28$25-$3-10.75%
Sbi Securities Co., Ltd.0.00%14$19$17-$2-12.32%
Ifp Advisors, Inc0.00%13$17$15-$2-9.00%
Zurcher Kantonalbank (Zurich Cantonalbank)0.00%2$3$2-$1-20.67%
Group One Trading Llc0.00%1$1$1+$0+19.00%
Triumph Capital Management0.00%1$1$1+$0+19.00%
Us Bancorp \De\0.00%1$1$1+$0+19.00%

Frequently asked questions about BTAI

  • Who owns the most BTAI stock?

    The largest holders of BTAI are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BIOXCEL THERAPEUTICS INC (BTAI).

  • Is BTAI widely held by superinvestors?

    Many widely followed stocks like BTAI appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BTAI is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.